In Brief | Published:


DDR pathway mediates radiosensitization in prostate cancer

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original article

    1. Sekhar, K. R. et al. Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway. PLOS ONE 14, e0214670 (2019)

    Download references

    Author information

    Correspondence to Louise Stone.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark